BACKGROUND: Pulsed field ablation (PFA) is a novel technology for catheter-based atrial arrhythmia treatment. Evidence of its application for ventricular arrhythmia ablation is still limited. In this study, we describe the feasibility and efficacy of focal PFA for premature ventricular contraction (PVC) ablation. METHODS: A prospective cohort of 20 patients referred for PVC ablation at 2 centers was enrolled, regardless of the presence of structural heart disease, PVC morphology, or previous ablation attempts. All procedures were performed using the CENTAURI System in combination with contact force sensing catheters and 3-dimensional electroanatomical mapping systems. Energy output and the number of applications were left to the operator’s discretion. RESULTS: Eleven (55%) procedures were conducted under general anesthesia, 6 (30%) under deep sedation, and 3 (15%) under light sedation. Muscular contraction was observed in one case (5%). Median procedural and fluoroscopy times were 95.5 and 6.55 minutes, respectively. The median number of PFA applications was 8 with a median contact force of 10 g . A statistically significant (76%) reduction was observed in mean peak-to-peak bipolar electrogram voltage before and after ablation (0.707 versus 0.098 mV; P =0.008). Ventricular irritative firing was observed in 11 (55%) patients after PFA. The median follow-up was 120 days. Acute procedural success was achieved in 17 of 20 (85% [95% CI, 0.70–1]) patients. Two of the patients with procedural failure had late success with >80% clinical PVC burden suppression during follow-up, and 2 of 17 patients with acute success had late PVC recurrence, which accounts for a total of 17 of 20 (85% [95% CI, 0.70–1]) patients with chronic success. Transient ST-segment depression occurred in 1 patient, and the right bundle branch block was induced in 2 others (permanently only in one case). CONCLUSIONS: PVC ablation using a focal PFA is feasible, effective, and safe, with promising acute and long-term results in several ventricular locations. Irritative firing is frequently observed. Coronary evaluation should be considered when targeting the outflow tract.
Background/Objectives: The cryoballoon (CB) has simplified pulmonary vein isolation (PVI) for treating atrial fibrillation (AF). Vein occlusion is usually assessed utilizing contrast media which entails possible risks and increases fluoroscopy exposure. Pressure-guided assessment of occlusion has emerged as a potential alternative. The objective of this study is to compare procedural characteristics and repeat-procedure findings of pressure-guided and contrast-guided assessment of vein occlusion. Methods: From July 2018 to December 2023, 1166 patients (485 [41%] female, mean age 65 ± 10 years) with AF (64% paroxysmal) undergoing CB-PVI were enrolled at a single-center, 368 (32%) underwent a contrast-guided and 798 (68%) a pressure-guided approach. Results: Procedure duration (90 ± 20 vs. 93 ± 23 min) and ablation time (1342 ± 361 vs. 1368 ± 406 s) were similar in pressure- and contrast- guided groups, and the acute success rate of PVI was high in both groups. The pressure-guided approach had shorter X-ray times (5.7 ± 3.4 vs. 9.5 ± 4.8 min, p < 0.0001) and lower X-ray doses (82 ± 78.9 vs. 586 ± 546 cGy/cm2, p < 0.0001). In 112 redo-procedures for arrhythmia recurrence after CB-PVI, durable isolation of all veins was observed more often after pressure-guided procedures (28/56 [50%] vs. 13/56 [23%]); per-vein durability was also higher (174/224 [78%] vs. 150/224 [67%], p = 0.015). Conclusions: Pressure-waveform guidance during CB-PVI is a feasible alternative to contrast-guided occlusion assessment and was associated with substantially lower intraprocedural fluoroscopy exposure. Repeat-procedure findings suggest a possible durability signal, but this observation should be considered exploratory and confirmed in prospective studies.